Evaluation of the efficacy and safety of HX-1 cardioplegia in on-pump cardiac surgery: a retrospective cohort study

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2300069884

Enrollment

Unknown

Registered

2023-03-28

Start date

2023-05-01

Completion date

Unknown

Last updated

2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients undergoinng on-pump cardiac surgery

Interventions

HX-1 Cardioplegia:None

HTK Cardioplegia:None

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients undergoing CPB cardiac surgery from January 1, 2019 to June 30, 2021

Exclusion criteria

Exclusion criteria: Patients undergoing heart transplantation surgery

Design outcomes

Primary

Measure	Time frame
Composite adverse event including all-cause mortality, rate of IABP and ECMO after surgery, and incidence of postoperative low cardiac output syndrome;	—

Secondary

Measure	Time frame
Perioperative requirement of blood products;New-onset postoperative neurological complications, hepatic insufficiency, and acute kidney injury;ICU duration and hospitalization time;	—

Countries

P.R. China

Contacts

Public ContactDu Lei

West China Hospital of Sichuan University

dulei@scu.edu.cn18980601926

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026